SCHEMBL379399

SCHEMBL379399

CC1(C)CCC(O)C(C)(C)N1[O]

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL668940 0.76 GAA (0.56) GAAL3MBTL1
SCHEMBL4802671 0.75
SCHEMBL2678629 0.74 GAA (0.38) GAAL3MBTL1
SCHEMBL4449961 0.74 GAA (0.60) GAAL3MBTL1
SCHEMBL7569934 0.73
SCHEMBL28277841 0.73 GAA (0.37) GAAL3MBTL1
SCHEMBL2912919 0.73
SCHEMBL5715928 0.72 SMN1; SMN2 (0.35) GAAL3MBTL1
SCHEMBL438903 0.72 SLC1A2 (0.42) L3MBTL1
SCHEMBL6567906 0.71 GAA (0.31) GAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113993835-A Method for producing glycerol mono (meth) acrylates 赢创运营有限公司 2022-01-28 CN claimed
US-20150159088-A1 COMPOUNDS AND LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2015-06-11 US claimed
EP-2398832-A1 POLYMERIZATION INHIBITOR COMPOSITION AND METHOD OF INHIBITING POLYMERIZATION OF DISTILLABLE MONOMERS Dow Global Technologies LLC (US) 2011-12-28 EP claimed
WO-2010096512-A1 POLYMERIZATION INHIBITOR COMPOSITION AND METHOD OF INHIBITING POLYMERIZATION OF DISTILLABLE MONOMERS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-08-26 WO claimed
EP-2142575-A1 PROCESS FOR THE PRODUCTION OF A (CO) POLYMER COMPOSITION BY MEDIATED FREE RADICAL CHAIN GROWTH POLYMERIZATION Dow Global Technologies Inc. (US) 2010-01-13 EP claimed
EP-2095421-A2 INDIVIDUALLY ENCAPSULATED SOLAR CELLS AND/OR SOLAR CELL STRINGS Nanosolar Inc. (US) 2009-09-02 EP claimed
WO-2008134131-A1 PROCESS FOR THE PRODUCTION OF A (CO) POLYMER COMPOSITION BY MEDIATED FREE RADICAL CHAIN GROWTH POLYMERIZATION DOW GLOBAL TECHNOLOGIES INC. (US) 2008-11-06 WO claimed
WO-2008014492-A2 INDIVIDUALLY ENCAPSULATED SOLAR CELLS AND/OR SOLAR CELL STRINGS NANOSOLAR, INC. (US) 2008-01-31 WO claimed
EP-1278712-A2 NITROAROMATIC SOLUBILIZER FOR NITROXYLS IN AROMATIC SOLVENTS Uniroyal Chemical Company, Inc. (US) 2003-01-29 EP claimed
EP-1248757-A1 INHIBITION OF POLYMERIZATION OF UNSATURATED MONOMERS Uniroyal Chemical Company, Inc. (US) 2002-10-16 EP claimed
WO-2001083567-A2 NITROAROMATIC SOLUBILIZER FOR NITROXYLS IN AROMATIC SOLVENTS UNIROYAL CHEMICAL COMPANY, INC. (US) 2001-11-08 WO claimed
WO-2001053235-A1 INHIBITION OF POLYMERIZATION OF UNSATURATED MONOMERS UNIROYAL CHEMICAL COMPANY, INC. (US) 2001-07-26 WO claimed
EP-4341238-A1 PROCESS FOR PREPARING A POLYMERIZATION-PRONE COMPOUND Röhm GmbH (DE) 2024-03-27 EP disclosed
WO-2022251381-A1 MODULATING EXPRESSION LEVEL OF A GENE ENCODING AN UNCOUPLING PROTEIN BY TREATING A HUMAN SUBJECT WITH A NITROXIDE HABASH LOUIS (US) 2022-12-01 WO disclosed
WO-2022243038-A1 PROCESS FOR PREPARING A POLYMERIZATION-PRONE COMPOUND RÖHM GMBH (DE) 2022-11-24 WO disclosed
US-20220155503-A1 CHEMICAL DIFFUSION TREATED VOLUME HOLOGRAMS AND METHODS FOR MAKING THE SAME META PLATFORMS TECHNOLOGIES, LLC 2022-05-19 US disclosed
EP-1689796-A1 (METH)ACRYLIC ACID ESTERS OF UNSATURATED AMINOALCOHOLS AND PRODUCTION THEREOF BASF AKTIENGESELLSCHAFT (DE) 2006-08-16 EP disclosed
EP-1670877-A1 RADICAL INTERCEPTORS AS STABILIZERS OF POLYMERIZABLE COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2006-06-21 EP disclosed
WO-2005058987-A1 (METH)ACRYLIC ACID ESTERS OF UNSATURATED AMINOALCOHOLS AND PRODUCTION THEREOF BASF AKTIENGESELLSCHAFT (DE) 2005-06-30 WO disclosed
WO-2005030907-A1 RADICAL INTERCEPTORS AS STABILIZERS OF POLYMERIZABLE COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150159088-A1 COMPOUNDS AND LIQUID-CRYSTALLINE MEDIUM VIM, NEFM, VCL GAA 3565/4885L3MBTL1 2778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.